Treatment of Diaphragmatic Paralysis Due to Reversible Metabolic Causes

Diaphragmatic weakness does not always reflect a permanent structural or neurological lesion. In a subset of patients, the dysfunction arises from reversible metabolic disturbances — ionic or hormonal in nature — making accurate identification of the underlying cause a central step in management.

Clinical scenario

Diaphragmatic dysfunction due to reversible metabolic causes, specifically ionic or hormonal alterations. In this population, the diaphragmatic weakness is expected to resolve once the metabolic disturbance is corrected — specific invasive intervention directed at the diaphragm is typically not required.

Treatment approach (partial)

Management targets the underlying metabolic cause directly. Depending on whether the disturbance is ionic or hormonal in nature, a distinct corrective strategy applies. The complete structured regimen — including selection criteria, sequencing, and monitoring — is available via the full protocol.

Clinical goal

Resolution of diaphragmatic weakness following correction of the causative metabolic disturbance.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1183/20734735.0218-2024

As previously described, there are reversible causes, namely metabolic causes (e.g. ionic or hormonal alterations), in which diaphragmatic weakness resolves with treatment (correction of ionic disturbances, replacement therapy with thyroid hormones), typically not necessitating specific treatment.

View source ↗